to experience the full functionality of mail.com.
Enhanced by Google
August 27, 2015
FDA lays out proposal for naming lower-cost biotech drugs
The Food and Drug Administration released its proposal Thursday for naming lower-cost biotech drugs, a critical step in ...
July 30, 2015
Amgen hikes 2015 forecast after 2Q increase in profit, sales
Amgen Inc. shares jumped in extended trading after the maker of osteoporosis drug Prolia easily beat Wall Street's ...
July 24, 2015
AbbVie beats 2Q profit forecasts, but sales fall short
Drugmaker AbbVie Inc. reported better-than-expected second-quarter profit, but its sales disappointed Wall Street. The North ...
July 21, 2015
Court ruling clears way for Novartis' low-cost biotech drug
A federal appeals court has ruled that Novartis can begin selling its lower-cost copy of an Amgen Inc. drug in September, ...
July 21, 2015
Europe approves Amgen's first-in-class cholesterol drug
Amgen on Tuesday received European approval for its first-of-a-kind cholesterol drug that lowers levels of the ...
June 10, 2015
FDA panel backs Amgen cholesterol drug for some patients
Federal health advisers said Wednesday that a highly-anticipated cholesterol-lowering drug from Amgen Inc. should be approved ...
June 09, 2015
FDA weighs target population for Amgen cholesterol drug
Federal health regulators said Monday a highly-anticipated, experimental drug from Amgen significantly lowers bad cholesterol
April 23, 2015
AbbVie raises outlook as Humira again delivers earnings beat
Drugmaker AbbVie is raising its full-year earnings guidance after reporting better-than-expected first quarter adjusted ...
April 21, 2015
Amgen tops estimates with 51 percent spike in 1Q profit
Amgen Inc. boosted its first-quarter profit by 51 percent, thanks to surging drug sales and ongoing cost cuts designed to ...
April 15, 2015
FDA approves new type of heart failure drug from Amgen
Patients with chronic heart failure, a disabling, deadly disease that worsens as the heart gradually pumps less efficiently, ...
March 15, 2015
Studies boost hopes for new class of cholesterol medicines
New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for ...
March 06, 2015
FDA approves first lower-cost biotech drug
Federal health officials on Friday approved the first lower-cost copy of a biotech drug in the U.S., a long-awaited milestone ...
March 05, 2015
AbbVie to buy leukemia drugmaker Pharmacyclics for $21B
AbbVie will spend about $21 billion to buy fellow drugmaker Pharmacyclics and add another major revenue producer to a ...